MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Market Cap 2011-2026 | EW
As of March 27, 2026 Edwards Lifesciences Corporation has a market cap of $ 46.4 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.8 B | 42.5 B | 53 B | 47.8 B | 70 B | 51.7 B | 48.7 B | 35.3 B | 26.7 B | 20.5 B | 16.9 B | 13.3 B | 7.31 B | 10.3 B | 8.97 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70 B | 7.31 B | 33.5 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M |  USA |
 |
Abbott Laboratories
ABT
|
196 B | $ 104.93 | 0.34 % | $ 183 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 167.25 | -5.68 % | $ 12.5 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Accuray Incorporated
ARAY
|
160 M | $ 0.4 | 6.74 % | $ 41.1 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 11.08 | -3.82 % | $ 1.66 B | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 34.41 | -2.65 % | $ 5.13 K | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 69.2 | -1.38 % | $ 102 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.17 | -2.34 % | $ 260 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 35.66 | -2.67 % | $ 1.11 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Electromed
ELMD
|
175 M | $ 24.33 | -0.51 % | $ 206 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.59 | -1.62 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
3.03 M | $ 2.21 | -2.64 % | $ 3.45 M | USA |
 |
Establishment Labs Holdings
ESTA
|
2.31 B | $ 56.38 | -5.9 % | $ 1.67 B |  Costa-rica |
 |
PAVmed
PAVM
|
16 M | $ 8.75 | -2.13 % | $ 63.3 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.54 | -0.03 % | $ 122 M | USA |
 |
InspireMD
NSPR
|
115 M | $ 1.65 | -4.75 % | $ 106 M | Israel |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 9.36 | -0.21 % | $ 721 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.3 | -3.08 % | $ 168 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 0.97 | -28.0 % | $ 15.6 M | USA |
 |
IRadimed Corporation
IRMD
|
1.25 B | $ 97.63 | -1.12 % | $ 1.24 B | USA |
 |
Penumbra
PEN
|
13.2 B | $ 335.13 | -0.38 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.74 | -3.73 % | $ 369 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 61.48 | -3.41 % | $ 3.35 B |  Britain |
 |
LENSAR
LNSR
|
130 M | $ 5.59 | 1.27 % | $ 64.4 M | USA |